SEC Form 4 · accession 0001179110-17-003676
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jared Watkin
Officer — Senior Vice President
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 5:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 28, 2017 | F | 2,496 | $45.46 | D | 49,481 | D | |
| Common shares without par value | Mar 1, 2017 | S | 970 | $45.39 | D | 48,511 | D | |
| Common shares without par valueF1 | holding | — | — | — | 446 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2017.
Remarks
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).